Applied Therapeutics, Inc.: cash and cash equivalents

What this measure means

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Exact concept: us-gaap:CashAndCashEquivalentsAtCarryingValue. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2018-12-31 to 2024-12-31. The SEC response was captured on 2026-09-21.

Selected filing history

Related financial histories

• Applied Therapeutics, Inc.: total assets
• Applied Therapeutics, Inc.: total liabilities
• Applied Therapeutics, Inc.: stockholders equity
• Applied Therapeutics, Inc.: net income or loss
• Applied Therapeutics, Inc.: operating cash flow
• Applied Therapeutics, Inc.: financing cash flow
• Applied Therapeutics, Inc.: investing cash flow
• Applied Therapeutics, Inc.: retained earnings or deficit
• Applied Therapeutics, Inc.: basic weighted-average shares
• Applied Therapeutics, Inc.: diluted weighted-average shares
• Applied Therapeutics, Inc.: basic earnings per share
• Applied Therapeutics, Inc.: diluted earnings per share
• Applied Therapeutics, Inc.: share-based compensation expense
• Applied Therapeutics, Inc.: operating income or loss
• Applied Therapeutics, Inc.: current assets
• Applied Therapeutics, Inc.: current liabilities
• Applied Therapeutics, Inc.: current accounts payable
• Applied Therapeutics, Inc.: operating expenses
• Applied Therapeutics, Inc.: research and development expense

Inspect the source

Entity

Applied Therapeutics, Inc. / CIK 0001697532

Captured

2026-09-21T17:24:29.252Z

SEC response SHA-256

5aa072f302db1f1691ba18b8f6ae327ceb4f62a11369aa7447e7bfeb173a8eff

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001697532.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))